{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "SPORT BEI KARDIOVASKUL\u00e4REN RISIKOFAKTOREN UND IM ALTER: Falls Personen mit kardiovaskul\u00e4ren Risikofaktoren oder im Alter von \u2265\u200a65 Jahren eine intensive sportliche Belastung planen, wird ihnen zur Risikominimierung des sportassoziierten pl\u00f6tzlichen Herztods eine kardiale Vorsorgeuntersuchung empfohlen. Zur individuellen Risikoeinordnung sollte beim Vorliegen von kardiovaskul\u00e4ren Risikofaktoren der ESC-Score Verwendung finden. SPORT BEI KARDIOVASKUL\u00e4REN ERKRANKUNGEN: \u2002Die erstmalig erschienenen Leitlinien der European Society of Cardiology (ESC) \u201eSportkardiologie und k\u00f6rperliche Aktivit\u00e4t bei Patienten mit kardiovaskul\u00e4rer Erkrankung\u201c (2020) 1 geben umfassende Trainingsempfehlungen zur Aus\u00fcbung von Freizeit- und Leistungssport f\u00fcr Patienten mit kardiovaskul\u00e4ren Erkrankungen. Dabei ist eine kardiale Eingangsuntersuchung zur individuellen Risikostratifizierung als Basis der Trainingsberatung unumg\u00e4nglich. Nur in Ausnahmef\u00e4llen wird von einer sportlichen Bet\u00e4tigung (passager) abgeraten. SPORT, COVID-19 UND HERZ: \u2002COVID-19 kann zu kardialen Sch\u00e4den f\u00fchren, wobei diese selten auch bei asymptomatischen und milden Krankheitsverl\u00e4ufen beobachtet wurden. Vor Wiederaufnahme intensiver sportlicher Aktivit\u00e4ten sollte, in Abh\u00e4ngigkeit von Krankheitsschwere und Symptomatik, die Sporttauglichkeit \u00fcberpr\u00fcft und dann individuell das weitere Vorgehen bez\u00fcglich des Trainingsaufbaus festgelegt werden."
      ],
      "CopyrightInformation": "Thieme. All rights reserved."
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34553352",
  "DateCompleted": {
    "Year": "2021",
    "Month": "09",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "09",
    "Day": "30"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "09",
        "Day": "22"
      }
    ],
    "Language": [
      "ger"
    ],
    "ELocationID": [
      "10.1055/a-1361-7592"
    ],
    "Journal": {
      "ISSN": "1439-4413",
      "JournalIssue": {
        "Volume": "146",
        "Issue": "19",
        "PubDate": {
          "Year": "2021",
          "Month": "Oct"
        }
      },
      "Title": "Deutsche medizinische Wochenschrift (1946)",
      "ISOAbbreviation": "Dtsch Med Wochenschr"
    },
    "ArticleTitle": "[Sports cardiology 2021 - what's new?].",
    "Pagination": {
      "StartPage": "1270",
      "EndPage": "1276",
      "MedlinePgn": "1270-1276"
    },
    "Abstract": {
      "AbstractText": [
        "The recently published guidelines \"Sports cardiology and exercise in patients with cardiovascular disease\" (2020) are the first of a kind by the European Society of Cardiology (ESC). The guidelines provide comprehensive training recommendations for patients with cardiovascular diseases or risk factors, covering the entire spectrum of cardiovascular diseases with case-specific recommendations for recreational and competitive sports.The ESC recognizes exercise as an essential part of both prevention and therapy of cardiovascular diseases, that - comparable to drug therapies - requires correct prescription.The initial cardiac examination is used for individual risk stratification and is indispensable for individualized training recommendations addressing training frequency, duration and intensity, as well as type of sport.Thus, the question is not whether a patient with cardiovascular disease shall be allowed to exercise, but rather how he can safely perform it. Only in exceptional cases exercise therapy is (temporarily) contraindicated.COVID-19 can lead to cardiovascular complications even in asymptomatic and mild disease courses. Before resuming intense sporting activities, different return-to-sports protocols have been introduced. The current consensus is that the extent of these examinations should be based on symptoms, severity and duration of COVID-19 and that individual return-to-training recommendations should be given."
      ],
      "CopyrightInformation": "Thieme. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medizinische Klinik I, Kardiologie und Angiologie, Universit\u00e4tsklinikum Gie\u00dfen."
          }
        ],
        "LastName": "Most",
        "ForeName": "Astrid",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medizinische Klinik I, Kardiologie und Angiologie, Universit\u00e4tsklinikum Gie\u00dfen."
          }
        ],
        "LastName": "Bauer",
        "ForeName": "Pascal",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ],
    "VernacularTitle": "Sportkardiologie 2021 \u2013 was gibt es Neues?"
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Dtsch Med Wochenschr",
    "NlmUniqueID": "0006723",
    "ISSNLinking": "0012-0472"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cardiovascular Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exercise"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Heart Disease Risk Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Practice Guidelines as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Return to Sport"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Sports"
    }
  ],
  "CoiStatement": "Dr. med. Astrid Most: keine wirtschaftlichen oder pers\u00f6nlichen VerbindungenDr. med. Pascal Bauer: Beratert\u00e4tigkeit f\u00fcr: Bristol Myers Squibb, Pfizer, Bayer, AMGEN, Boehringer Ingelheim. Vortragst\u00e4tigkeit f\u00fcr: Boehringer Ingelheim, Sanofi Genzyme, AMGEN, Bristol Myers Squibb, Bayer, Pfizer. Mitgliedschaften: Stellvertretender Sprecher der AG 32 Sportkardiologie der DGK."
}